Medpace 

M$6,890
115
+M$0+0% Friday 15:19

统计数据

当日最高
-
当日最低
-
52周最高
-
52周最低
-
成交量
-
平均成交量
-
市值
133.17B
市盈率
33.63
股息收益率
-
股息
-

即将到来

收益

21Oct预期
Q1 2024
Q2 2024
下一个
42.22
46.62
51.02
55.42
预期每股收益
55.4189644851
实际每股收益
N/A

人们还关注

此列表基于关注MEDP.MX的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
首席执行官
Dr. August James Troendle M.D.
员工
5000
国家
United States
ISIN
US58506Q1094

上市公司